Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „regimen“
Suchtreffer
Begriffe & Kennungen
Alunbrig · 4.8 · Peripheral neuropathy adverse reactions were reported in 20% of patients treated at the 180 mg regimen. Thirty
Eintrag öffnenAlunbrig · 4.8 · The data described below reflect exposure to Alunbrig at the recommended dosing regimen in three clinical tria
Eintrag öffnenAlymsys · 4.5 · EGFR monoclonal antibodies in combination with bevacizumab chemotherapy regimens
Eintrag öffnenAntineoplastische Kombinationschemotherapie-Protokolle
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.5 · In case of withdrawal of ritonavir from the recommended atazanavir-boosted regimen (see section 4.4)
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.8 · Laboratory abnormalities The most frequently reported laboratory abnormality in patients receiving regimens co
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.8 · Other marked clinical laboratory abnormalities (Grade 3 or 4) reported in ≥ 2% of patients receiving regimens
Eintrag öffnenAvastin · 4.5 · EGFR monoclonal antibodies in combination with bevacizumab chemotherapy regimens No interaction studies have b
Eintrag öffnenAvzivi · 4.5 · EGFR monoclonal antibodies in combination with bevacizumab chemotherapy regimens No interaction studies have b
Eintrag öffnenAybintio · 4.5 · EGFR monoclonal antibodies in combination with bevacizumab chemotherapy regimens No interaction studies have b
Eintrag öffnenBimzelx · 4.8 · Approximately 59% of HS patients treated with bimekizumab up to 48 weeks at the recommended dosing regimen (32
Eintrag öffnenBortezomib Accord · 4.8 · Peripheral neuropathy in combination regimens Multiple myeloma In studies in which bortezomib was administered
Eintrag öffnenBortezomib Accord · 4.8 · Peripheral neuropathy in combination regimens Multiple myeloma In studies in which bortezomib was administered
Eintrag öffnenBortezomib Fresenius Kabi · 4.8 · Peripheral neuropathy in combination regimens Multiple myeloma In trials in which bortezomib was administered
Eintrag öffnenBortezomib Fresenius Kabi · 4.8 · Peripheral neuropathy in combination regimens Multiple myeloma In trials in which bortezomib was administered
Eintrag öffnenBortezomib Sun · 4.8 · Peripheral neuropathy in combination regimens Multiple myeloma In trials in which bortezomib was administered
Eintrag öffnenBronchitol · 4.8 · Therapeutic dose regimen The most commonly observed adverse reaction associated with the use of Bronchitol is
Eintrag öffnenBronchitol · 4.8 · Therapeutic dose regimen(6 to 17 years of age) The most commonly observed adverse reaction associated with the
Eintrag öffnenBusulfan Fresenius Kabi · 4.5 · In adults, for the BuCy2 regimen it has been reported that the time interval between the last oral busulfan ad
Eintrag öffnenBusulfan Fresenius Kabi · 4.5 · In paediatric population, for the BuMel regimen it has been reported that the administration of melphalan less
Eintrag öffnen